TRILLIUM THERAPEUTICS INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 3252
 
  
 
C07D HETEROCYCLIC COMPOUNDS 3159
 
  
 
C07K PEPTIDES 3133
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2136
 
  
 
A63H TOYS, e.g. TOPS, DOLLS, HOOPS, BUILDING BLOCKS131

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0050,993 NOVEL FLUORINATED DERIVATIVES AS EGFR INHIBITORS USEFUL FOR TREATING CANCERSFeb 03, 16Feb 22, 18[C07D, C07C]
2018/0016,227 PROCESS FOR THE SYNTHESIS OF DIFLUOROMETHYL ETHER-BASED COMPOUNDSFeb 03, 16Jan 18, 18[C07D, C07C]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9441012 Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitorsAug 13, 13Sep 13, 16[A61K, C07K]
7438623 Geometric construction systemSep 06, 05Oct 21, 08[A63H]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0347,792 FLUORINATED EPOXYKETONE-BASED COMPOUNDS AND USES THEREOF AS PROTEASOME INHIBITORSAbandonedAug 12, 16Dec 01, 16[C07K]
2015/0218,212 FLUORINATED EPOXYKETONE-BASED TETRAPEPTIDE COMPOUNDS AND USES THEREOF AS PROTEASOME INHIBITORSAbandonedAug 21, 13Aug 06, 15[A61K, C07K]
2013/0102,532 HB-EGF Composition and Use Thereof to Treat a Condition Associated With Enhanced Urothelium PermeabilityAbandonedApr 12, 11Apr 25, 13[A61K]
2012/0264,145 Assay for Soluble CD200AbandonedMay 18, 12Oct 18, 12[G01N]
8206897 Assay for soluble CD200ExpiredJul 29, 08Jun 26, 12[C12Q]
8187598 Methods of treating cancer by administering antibodies to CD200ExpiredFeb 11, 11May 29, 12[A61K]
2011/0206,668 METHODS AND COMPOSITIONS FOR MODULATING IMMUNITYAbandonedFeb 03, 11Aug 25, 11[A61K, A61P]
2011/0189,201 MODULATION OF BONE DEVELOPMENTAbandonedApr 11, 11Aug 04, 11[A61K, C12Q, C12N, A61P]
7902151 Methods and compositions for modulating immunityExpiredMay 22, 09Mar 08, 11[A61K]
7887798 Methods of treating cancer by administering antibodies to CD200ExpiredOct 07, 08Feb 15, 11[A61K]
2009/0214,573 MODULATION OF BNE DEVELOPMENTAbandonedFeb 27, 09Aug 27, 09[A61K, G01N, A61P]
7553811 Methods and compositions for modulating immunityExpiredApr 18, 07Jun 30, 09[A61K, C07K]
7452536 Methods of treating cancer by administering antibodies to CD200ExpiredMay 25, 07Nov 18, 08[A61K]
2008/0267,967 MODULATION OF CD200 RECEPTORSAbandonedMar 27, 08Oct 30, 08[A61K, C12Q, C12N, G01N, A61P, C07K]
7368535 CD200 receptorsExpiredMay 24, 02May 06, 08[C07K]
7291330 MD-1 inhibitors as immune suppressantsExpiredMar 16, 01Nov 06, 07[A61K]
7238352 Methods and compositions for modulating tumor growthExpiredJul 29, 05Jul 03, 07[A61K]
7223729 Methods of treating allergy by administering a CD200 proteinExpiredMay 21, 04May 29, 07[A61K]
7205386 Truncated CD200ExpiredNov 22, 01Apr 17, 07[C07K]
7196243 Transgenic animal containing CD200 and uses thereforExpiredApr 03, 03Mar 27, 07[A01K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.